Want to see JP:4936 full AI Analyst Report?
AXXZIA, Inc. (4936) AI Stock Analysis
AXXZIA, Inc.
(TSE/TYO:4936)
The overall score is heavily pressured by the company's transition to unprofitability, which is the most significant risk. The income statement losses and deteriorating cash flow undermine the business's fundamental health. This is compounded by a persistently bearish technical trend across all timeframes. The primary mitigating factor is the exceptionally strong, debt-free balance sheet, which provides a critical buffer and time for a potential turnaround, but it is not enough to offset the severe operational and market headwinds.
AXXZIA, Inc. (4936) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 6.68B
- Dividend Yield
- 3.42%
- Average Volume (3M)
- 45.09K
- Price to Earnings (P/E)
- -14.4
- Beta (1Y)
- 0.93
- Revenue Growth
- -0.08%
- EPS Growth
- -246.12%
- Country
- Japan
- Employees
- 248
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
AXXZIA, Inc. Business Overview & Revenue Model
Company Description
AXXZIA Inc. manufactures and sells cosmetics and supplements in Japan. The company offers eyecare, skincare, supplements and drinks, salon care, hair care, hair styling, and beauty device products under the AXXZIA, AGtheory, LisBeau, LisBlanc, The B,...
AXXZIA, Inc. Financial Statement Overview
Summary
Financial performance is deeply divided. The balance sheet is a fortress with minimal debt (D/E 0.08), providing stability. However, the income statement shows a severe profitability collapse into net losses, and cash flow generation has deteriorated significantly. The overall financial health is weak due to the critical inability to convert revenue growth into profit.
Income Statement
35NegativeBalance Sheet
78PositiveCash Flow
30Negative| Breakdown | TTM | Jul 2026 | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.47B | 13.47B | 13.48B | 12.19B | 11.34B | 8.22B |
| Gross Profit | 9.95B | 9.95B | 9.92B | 9.61B | 8.94B | 6.22B |
| EBITDA | 99.04M | 30.14M | 746.64M | 1.29B | 2.06B | 1.84B |
| Net Income | -464.91M | -464.91M | 354.28M | 794.35M | 1.33B | 1.12B |
Balance Sheet | ||||||
| Total Assets | 8.94B | 8.94B | 9.62B | 10.54B | 10.70B | 10.05B |
| Cash, Cash Equivalents and Short-Term Investments | 4.00B | 4.00B | 3.99B | 4.93B | 5.79B | 6.39B |
| Total Debt | 570.96M | 570.96M | 860.67M | 975.56M | 632.25M | 654.12M |
| Total Liabilities | 1.80B | 1.80B | 2.04B | 2.01B | 1.80B | 1.66B |
| Stockholders Equity | 7.14B | 7.14B | 7.57B | 8.53B | 8.90B | 8.40B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 218.46M | 640.22M | 410.77M | 282.75M | 732.86M |
| Operating Cash Flow | 0 | 298.86M | 781.65M | 800.36M | 707.85M | 797.69M |
| Investing Cash Flow | 0 | -106.92M | -158.54M | -626.66M | -438.69M | -775.36M |
| Financing Cash Flow | 0 | -452.29M | -1.48B | -1.55B | -862.75M | 386.43M |
AXXZIA, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4936, the sentiment is Negative. The current price of 286.00 is below the 20-day moving average (MA) of 298.90, below the 50-day MA of 308.44, and below the 200-day MA of 337.28, indicating a bearish trend. The MACD of -2.26 indicates Positive momentum. The RSI at 38.11 is Neutral, neither overbought nor oversold. The STOCH value of 5.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4936.
AXXZIA, Inc. Peers Comparison
Overall Rating
JP:492580Outperform
JP:491871Outperform
JP:492065Neutral
JP:492665Neutral
JP:493453Neutral- JP:493644Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4925 | 80Outperform | JPY 6.32B | 9.28 | ― | 2.39% | 0.16% | 6.35% |
| JP:4918 | 71Outperform | JPY 1.71B | 8.86 | ― | 4.97% | -6.17% | -55.84% |
| JP:4920 | 65Neutral | JPY 2.32B | 8.64 | ― | 2.71% | 9.96% | 2053.18% |
| JP:4926 | 65Neutral | JPY 5.30B | 28.91 | ― | 1.61% | 3.17% | -27.27% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| JP:4934 | 53Neutral | JPY 4.86B | 13.34 | ― | ― | -14.09% | -22.72% |
| JP:4936 | 44Neutral | JPY 7.04B | -14.36 | ― | 3.42% | -0.08% | -246.12% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4936 | AXXZIA, Inc. | 286.00 | -153.01 | -34.85% | |
| JP:4918 | Ivy Cosmetics Corporation | 298.00 | -20.81 | -6.53% | |
| JP:4920 | Nippon Shikizai, Inc. | 1081.00 | 36.38 | 3.48% | |
| JP:4925 | HABA Laboratories, Inc. | 1671.00 | 46.91 | 2.89% | |
| JP:4926 | C'BON COSMETICS Co., Ltd. | 1242.00 | 69.27 | 5.91% | |
| JP:4934 | Premier Anti-Aging Co., Ltd. | 552.00 | -155.00 | -21.92% |
AXXZIA, Inc. Corporate Events
AXXZIA Overhauls Governance With New Mandate-Based Executive Officer System
AXXZIA Inc. has resolved to introduce a mandate-based Executive Officer System to strengthen its corporate governance and better separate management oversight from business execution. The move replaces its existing employment-based executive officer...
AXXZIA Slashes FY2026 Earnings Outlook on China Slowdown and Rising Costs
AXXZIA Inc. has sharply revised its consolidated earnings forecast for the fiscal year ending July 31, 2026, cutting expected net sales and now projecting an operating loss instead of a profit, as profit attributable to owners of the parent is also f...
AXXZIA Swings to Loss and Cuts Outlook but Maintains Dividend
AXXZIA reported net sales of ¥9.89 billion for the first three quarters of the fiscal year ending July 2026, a 1.9% decline year on year, and swung to an operating loss of ¥48 million as profits sharply deteriorated. Profit attributable to...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 15, 2026